Astrazeneca AZN
NYSE AZN
$157.68 -3.79 (-2.35%)
As of: Oct 1, 2026 · 3:59 PM EDT

Astrazeneca (AZN) Restructuring Costs (2021)

Updated

Astrazeneca (AZN) reported Restructuring Costs of $57 million for FY2023, down 69.5% from $187 million in FY2022.

Analysis

Astrazeneca (AZN) Restructuring Costs (2021) Analysis & Trends

Dating back to FY2017, Astrazeneca's Restructuring Costs record includes 7 years.

  • Restructuring Costs has a five-year compound annual growth rate of 6.8% (FY2018 to FY2023).
  • The FY2023 figure ranks as the lowest annual Restructuring Costs since FY2020.
  • According to Business Quant data, Restructuring Costs came in at $187 million in FY2022 (-13.8%), $217 million in FY2021 (+734.6%), $26 million in FY2020 (-81.0%) and $137 million in FY2019 (+234.1%).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Bristol Myers Squibb 127.55 Bn 78.82 Bn 9.25 Bn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 -1.00 Mn
API Access

Astrazeneca Restructuring Costs API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=restructuring-costs&ticker=AZN&period=max&api_key=YOUR_API_KEY